Zeier M - Search Results

1

Donor-Derived Cell-Free DNA (dd-cfDNA) in Kidney Transplant Recipients With Indication Biopsy-Results of a Prospective Single-Center Trial.

Benning L, Morath C, Fink A, Rudek M, Speer C, Kälble F, Nusshag C, Beimler J, Schwab C, Waldherr R, Zeier M, Süsal C, Tran TH. Benning L, et al. Among authors: zeier m. Transpl Int. 2023 Nov 3;36:11899. doi: 10.3389/ti.2023.11899. eCollection 2023. Transpl Int. 2023. PMID: 38020751 Free PMC article. Clinical Trial.

2

Successful deceased-donor kidney transplantation in crossmatch-positive patients with peritransplant plasma exchange and Rituximab.

Beimler JH, Morath C, Schmidt J, Ovens J, Opelz G, Rahmel A, Zeier M, Süsal C. Beimler JH, et al. Among authors: zeier m. Transplantation. 2009 Mar 15;87(5):668-71. doi: 10.1097/TP.0b013e318198a376. Transplantation. 2009. PMID: 19295310

3

An integrative approach for the transplantation of high-risk sensitized patients.

Morath C, Beimler J, Opelz G, Ovens J, Scherer S, Schmidt J, Schmied B, Gross ML, Schwenger V, Zeier M, Süsal C. Morath C, et al. Among authors: zeier m. Transplantation. 2010 Sep 27;90(6):645-53. doi: 10.1097/TP.0b013e3181ea3985. Transplantation. 2010. PMID: 20671598

4

Kidney transplantation for high-risk sensitized patients - the "Heidelberg algorithm".

Morath C, Opelz G, Zeier M, Süsal C. Morath C, et al. Among authors: zeier m. Transplant Proc. 2011 Apr;43(3):801-4. doi: 10.1016/j.transproceed.2011.02.074. Transplant Proc. 2011. PMID: 21486601

5

Living donor kidney transplantation in crossmatch-positive patients enabled by peritransplant immunoadsorption and anti-CD20 therapy.

Morath C, Beimler J, Opelz G, Scherer S, Schmidt J, Macher-Goeppinger S, Klein K, Sommerer C, Schwenger V, Zeier M, Süsal C. Morath C, et al. Among authors: zeier m. Transpl Int. 2012 May;25(5):506-17. doi: 10.1111/j.1432-2277.2012.01447.x. Epub 2012 Feb 29. Transpl Int. 2012. PMID: 22372718 Free article.

6

Prevention of antibody-mediated kidney transplant rejection.

Morath C, Opelz G, Zeier M, Süsal C. Morath C, et al. Among authors: zeier m. Transpl Int. 2012 Jun;25(6):633-45. doi: 10.1111/j.1432-2277.2012.01490.x. Transpl Int. 2012. PMID: 22587522 Free article. Review.

7

Recent developments in desensitization of crossmatch-positive kidney transplant recipients.

Morath C, Opelz G, Zeier M, Süsal C. Morath C, et al. Among authors: zeier m. Transplant Proc. 2012 Jul-Aug;44(6):1648-51. doi: 10.1016/j.transproceed.2012.04.006. Transplant Proc. 2012. PMID: 22841236 Review.

8

Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers.

Opelz G, Morath C, Süsal C, Tran TH, Zeier M, Döhler B. Opelz G, et al. Among authors: zeier m. Transplantation. 2015 Feb;99(2):400-4. doi: 10.1097/TP.0000000000000312. Transplantation. 2015. PMID: 25050471

9

Switch to an everolimus-facilitated cyclosporine A sparing immunosuppression improves glycemic control in selected kidney transplant recipients.

Kälble F, Seckinger J, Schaier M, Morath C, Schwenger V, Zeier M, Sommerer C. Kälble F, et al. Among authors: zeier m. Clin Transplant. 2017 Aug;31(8). doi: 10.1111/ctr.13024. Epub 2017 Jul 7. Clin Transplant. 2017. PMID: 28581202

10

Increased risk of infection-associated death with incompatible kidney transplantations.

Morath C, Zeier M, Süsal C. Morath C, et al. Among authors: zeier m. Transpl Int. 2017 Dec;30(12):1209-1211. doi: 10.1111/tri.12995. Transpl Int. 2017. PMID: 28585408 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

590 results

Search Page